31 Mar 2023
Assets111.55
Total Income113.12
EBITDA12.66
Profit After Tax5.82
NET Worth7.37
Reserves and Surplus-4.63
Total Borrowing66.39
Open 26th Aug 2025 · Close 29th Aug 2025 · Listing 3rd Sep 2025
The shares listed at ₹92.00, a 1.10% move from the issue price. Anlon Healthcare is a Mainboard IPO with an issue size of ₹121.03 crore, proposed for listing on BSE, NSE. The offer opens on 26th Aug 2025 and closes on 29th Aug 2025. The issue structure includes a fresh issue of ₹121.03 crore. The current listing schedule points to 3rd Sep 2025.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 164 | ₹14,924 |
| Object | Amount |
|---|---|
| Funding capital expenditure requirements for Proposed Expansion | ₹30.72 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | ₹5.00 Cr |
| Funding the working capital requirements of the Company | ₹43.15 Cr |
| General Corporate Purposes | ₹27.03 Cr |
| Issue Expenses | ₹15.13 Cr |
| Total | ₹121.03 Cr |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 40.45% |
| ROCE | 21.93% |
| Debt / Equity | 0.73% |
| RoNW | 25.51% |
| PAT Margin | 17.06% |
| EBITDA Margin | 26.88% |
| Price to Book Value | 4.51 |
| Expense | Amount |
|---|---|
| Funding capital expenditure requirements for Proposed Expansion | ₹30.72 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | ₹5.00 Cr |
| Funding the working capital requirements of the Company | ₹43.15 Cr |
| General Corporate Purposes | ₹27.03 Cr |
| Issue Expenses | ₹15.13 Cr |
| Total | ₹121.03 Cr |